Moreover, the proportion of cells expressing ALDH1A1 (52.1% in MZ-CRC-1 vs. 93% in TT) and CD44 (47.6% in MZ-CRC-1 vs. 48.8% in TT) was higher in TT cells. This evidence concerns the gene ALDH1A1 and colorectal carcinoma.